Tokyo Tape
Sign in
← GNI Group

Quarterly report · Q1

2160.TEDINET S100QRIK
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥4.2bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥17.4bn2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥3.9bn2022-01-01 → 2022-03-31Cons.Revenue IFRS
Operating income¥398m2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥479m2022-01-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax−¥65m2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥768m2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥347m2022-01-01 → 2022-03-31Cons.Profit loss before tax IFRS
Net income (owners)−¥3m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥389m2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥351m2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income−¥342m2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Net income−¥868m2022-01-01 → 2022-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥72m2022-01-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥34.1bnat 2023-03-31Cons.Assets IFRS
Total assets¥33.9bnat 2022-12-31Cons.Assets IFRS
Total assets¥32.6bnat 2022-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥14.3bnat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥14.1bnat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥19.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥19.8bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥20.5bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥19.3bnat 2021-12-31dCons.Equity IFRS
Equity (owners)¥21.2bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥21.0bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥20.3bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥10.6bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥11.0bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.8bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.4bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥710m2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥393m2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥426m2022-01-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥1.2bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥4.1bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥298m2022-01-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥52m2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥646m2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥331m2022-01-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-0.062023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥8.192022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥7.42022-01-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-0.062023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥8.112022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥7.362022-01-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio62.2%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio61.8%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.4%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 22
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥23m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥23m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue2023-01-01 → 2023-03-31¥623m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue external2023-01-01 → 2023-03-31¥600m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥23m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentsegment profit2023-01-01 → 2023-03-31¥248m
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue2023-01-01 → 2023-03-31¥3.6bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue external2023-01-01 → 2023-03-31¥3.6bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentsegment profit2023-01-01 → 2023-03-31¥149m
—segment totalrevenue2023-01-01 → 2023-03-31¥4.2bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥4.2bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥23m
—segment totalsegment profit2023-01-01 → 2023-03-31¥398m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue2022-01-01 → 2022-03-31¥532m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue external2022-01-01 → 2022-03-31¥532m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentsegment profit2022-01-01 → 2022-03-31¥255m
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue2022-01-01 → 2022-03-31¥3.4bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue external2022-01-01 → 2022-03-31¥3.4bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentsegment profit2022-01-01 → 2022-03-31¥224m
—segment totalrevenue2022-01-01 → 2022-03-31¥3.9bn
—segment totalrevenue external2022-01-01 → 2022-03-31¥3.9bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥479m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 547
ItemContextValueUnit
Gross profit IFRSPrior1YTDDuration3384048000JPY
Gross profit IFRSCurrentYTDDuration3632777000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration2458324000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration2646363000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration468870000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration635649000JPY
Other income IFRSPrior1YTDDuration39628000JPY
Other income IFRSCurrentYTDDuration132214000JPY
Other expenses IFRSPrior1YTDDuration17555000JPY
Other expenses IFRSCurrentYTDDuration85381000JPY
Operating profit loss IFRSPrior1YTDDuration478926000JPY
Operating profit loss IFRSCurrentYTDDuration397598000JPY
Finance income IFRSPrior1YTDDuration54672000JPY
Finance income IFRSCurrentYTDDuration49329000JPY
Finance costs IFRSPrior1YTDDuration186173000JPY
Finance costs IFRSCurrentYTDDuration239599000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration－JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-272262000JPY
Profit loss before tax IFRSPrior1YTDDuration347425000JPY
Profit loss before tax IFRSCurrentYTDDuration-64934000JPY
Income tax expense IFRSPrior1YTDDuration275136000JPY
Income tax expense IFRSCurrentYTDDuration276810000JPY
Profit loss IFRSPrior1YTDDuration72289000JPY
Profit loss IFRSCurrentYTDDuration-341745000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration351014000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration-2874000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration-278725000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration-338870000JPY
Basic earnings loss per share IFRSPrior1YTDDuration7.40
Basic earnings loss per share IFRSCurrentYTDDuration-0.06
Diluted earnings loss per share IFRSPrior1YTDDuration7.36
Diluted earnings loss per share IFRSCurrentYTDDuration-0.06
Profit loss IFRSPrior1YTDDuration72289000JPY
Profit loss IFRSCurrentYTDDuration-341745000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration1029148000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration282489000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration－JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration2222000JPY
Other comprehensive income IFRSPrior1YTDDuration1029148000JPY
Other comprehensive income IFRSCurrentYTDDuration284712000JPY
Comprehensive income IFRSPrior1YTDDuration1101437000JPY
Comprehensive income IFRSCurrentYTDDuration-57033000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration1355849000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration203671000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration-254412000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration-260704000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember10884332000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember6224649000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-645000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember307535000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass